Soliqua 100/33 and Belching - a phase IV clinical study of FDA data
Belching is reported only by a few people who take Soliqua 100/33.
The phase IV clinical study analyzes which people take Soliqua 100/33 and have Belching. It is created by eHealthMe based on reports of 1,966 people who have side effects while taking Soliqua 100/33 from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,966 people reported to have side effects when taking Soliqua 100/33.
Among them, 2 people (0.1%) have Belching.
What is Soliqua 100/33?
Soliqua 100/33 has active ingredients of insulin glargine; lixisenatide. eHealthMe is studying from 1,971 Soliqua 100/33 users for its effectiveness, alternative drugs and more.
What is Belching?
Belching (release of gas from the digestive tract) is found to be associated with 2,129 drugs and 1,490 conditions by eHealthMe.
Number of Soliqua 100/33 and Belching reports submitted per year:
Gender of people who have Belching when taking Soliqua 100/33 *:
- female: 50 %
- male: 50 %
Age of people who have Belching when taking Soliqua 100/33 *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common side effects people have besides Belching *:
- Flatulence (flatus expelled through the anus): 1 person, 50.00%
- Diarrhea: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Soliqua 100/33 and have Belching?Check whether Belching is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Belching and when was it recovered:
Expand to all the drugs that have ingredients of insulin glargine; lixisenatide:
Alternative drugs to, pros and cons of Soliqua 100/33:
- Soliqua 100/33 (1,971 reports)
Belching treatments and more:
- Belching (16,468 reports)
COVID vaccines that are related to Belching:
- Belching in Moderna COVID Vaccine
- Belching in Pfizer BioNTech Covid Vaccine
- Belching in Johnson and Johnson Covid Vaccine
Common drugs associated with Belching:
- Metformin: 1,163 reports
- Aspirin: 971 reports
- Nexium: 950 reports
- Byetta: 922 reports
- Trulicity: 888 reports
- Victoza: 625 reports
- Lisinopril: 589 reports
- Omeprazole: 572 reports
- Prilosec: 500 reports
- Synthroid: 494 reports
All the drugs that are associated with Belching:
- Belching (2,129 drugs)
Common conditions associated with Belching:
- Type 2 diabetes: 2,088 reports
- High blood cholesterol: 927 reports
- Gastroesophageal reflux disease: 801 reports
- High blood pressure: 741 reports
- Diabetes: 480 reports
All the conditions that are associated with Belching:
- Belching (1,490 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on insulin glargine; lixisenatide (the active ingredients of Soliqua 100/33) and Soliqua 100/33 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lozol and Myopathy Aggravated - a second ago
- Retrovir and Back Pain - 9 seconds ago
- Melphalan and Weight Loss - 13 seconds ago
- Cylert and Hallucination, Auditory - 32 seconds ago
- Tegretol-Xr and Tremor - 38 seconds ago
- Fingolimod Hydrochloride and Speech Disorder - 40 seconds ago
- Centrum and Hysterectomy - 47 seconds ago
- Pantoprazole and Pleurothotonus - 57 seconds ago
- Qvar and Occult Blood Positive - a minute ago
- Ketoprofen and Procedural Haemorrhage - a minute ago